Paxman AB's Total Assets for the quarter that ended in Mar. 2026 was $51.00 Mil.
Warning Sign:
If a company builds assets at 33.2% a year, faster than its revenue growth rate of 25.9% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Paxman AB's average Total Assets Growth Rate was 119.00% per year.
During the past 3 years, the average Total Assets Growth Rate was 38.20% per year.
During the past 5 years, the average Total Assets Growth Rate was 33.20% per year.
During the past 9 years, Paxman AB's highest 3-Year average Total Assets Growth Rate was 38.20%. The lowest was 17.70%. And the median was 25.00%.
Total Assets is connected with ROA %. Paxman AB's annualizedROA % for the quarter that ended in Mar. 2026 was -0.10%. Total Assets is also linked to Revenue through Asset Turnover. Paxman AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.19.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Paxman AB's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Paxman AB Total Assets Related Terms
Paxman AB Total Assets Historical Data
* Premium members only.
The historical data trend for Paxman AB's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Paxman AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paxman AB (PXMBF) has a Total Assets of $51.00 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Paxman AB and its competitors.
Is Paxman AB's Total Assets too high?
Paxman AB's current Total Assets is $51.00 Mil. Overall, Paxman AB has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Total Assets compare to ABT and SYK?
Paxman AB's Total Assets of $51.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Paxman AB and its competitors. Paxman AB's current Total Assets is $51.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Total Assets of $51.00 Mil. The stock's GF Value™ is $4.38, compared to a current price of $3.50 — trading 20.1% below its estimated fair value. The current Total Assets is $51.00 Mil. Paxman AB's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Total Assets is $51.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 20.1% below its estimated GF Value™ of $4.38.
Key valuation signals for PXMBF:
Total Assets: $51.00 Mil
GF Value™: $4.38 vs. price of $3.50 (20.1% below fair value)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
77GF Score
Get the complete analysis for PXMBF
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
